Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Current Opinion in Chemical Biology|October 8, 2019
Peptides and peptidomimetics as inhibitors of protein-protein interactions involving β-sheet secondary structuresJosé Laxio Arenas, Julia Kaffy, Sandrine Ongeri
Current Pharmaceutical Design|November 28, 2012
Non-covalent proteasome inhibitorsJulia Kaffy, Guillaume Bernadat, Sandrine Ongeri
Journal of Chromatography. A|October 18, 2018
A capillary zone electrophoresis method to investigate the oligomerization of the human Islet Amyloid Polypeptide involved in Type 2 DiabetesCorentin Berardet, Julia Kaffy, Sandrine Ongeri, et al.
ACS Chemical Neuroscience|July 20, 2018
Binding Modes of a Glycopeptidomimetic Molecule on Aβ Protofibrils: Implication for Its Inhibition MechanismLinh Tran, Julia Kaffy, Sandrine Ongeri, et al.
Organic & Biomolecular Chemistry|July 7, 2005
Synthesis and biological evaluation of vinylogous combretastatin A-4 derivativesJulia Kaffy, Renée Pontikis, Jean-Claude Florent, et al.
ACS Organic & Inorganic Au|December 8, 2025
Access to <i>N</i>‑Fluorinated Azapeptides and Azapeptoids as Peptidomimetic ScaffoldsDimitra Kyrko, Tingting Cao, Pascal Retailleau, et al.
Electrophoresis|September 16, 2014
An improved capillary electrophoresis method for in vitro monitoring of the challenging early steps of Aβ1-42 peptide oligomerization: application to anti-Alzheimer's drug discoveryDimitri Brinet, Julia Kaffy, Farid Oukacine, et al.
Neoplasia (New York, N.Y.)|July 27, 2006
Early effects of combretastatin A4 phosphate assessed by anatomic and carbogen-based functional magnetic resonance imaging on rat bladder tumors implanted in nude miceCarole D Thomas, Christine Walczak, Julia Kaffy, et al.
Bioorganic & Medicinal Chemistry|March 3, 2006
Isoxazole-type derivatives related to combretastatin A-4, synthesis and biological evaluationJulia Kaffy, Renée Pontikis, Danièle Carrez, et al.
Talanta|February 4, 2017
In vitro monitoring of amyloid β-peptide oligomerization by Electrospray differential mobility analysis: An alternative tool to evaluate Alzheimer's disease drug candidatesDimitri Brinet, François Gaie-Levrel, Vincent Delatour, et al.
Pageof 3